Does Intracellular Metabolism Render Gemcitabine Uptake Undetectable in Mass Spectrometry?

The ergothioneine transporter (ETT): substrates and locations, an inventory

(2021) Dirk Gründemann et al.   FEBS LETTERS

DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia

(2020) Daelynn R. Buelow et al.   CTS-Clinical and Translational Science

Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1)

(2019) Anna Vlachodimou et al.   BIOCHEMICAL PHARMACOLOGY

Substrate Selectivity Check of the Ergothioneine Transporter

(2018) Julia Tschirka et al.   DRUG METABOLISM AND DISPOSITION

Emerging Roles of Nucleoside Transporters

(2018) Marçal Pastor-Anglada et al.   Frontiers in Pharmacology

The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey

(2016) J. D. Young   BIOCHEMICAL SOCIETY TRANSACTIONS

Equilibrative nucleoside transporters—A review

(2016) Rebba C. Boswell-Casteel et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

SLC22A13 catalyses unidirectional efflux of aspartate and glutamate at the basolateral membrane of type A intercalated cells in the renal collecting duct

(2013) Christian Schulz et al.   BIOCHEMICAL JOURNAL

The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29

(2013) James D. Young et al.   MOLECULAR ASPECTS OF MEDICINE

Human Concentrative Nucleoside Transporter 3 Transfection with Ultrasound and Microbubbles in Nucleoside Transport Deficient HEK293 Cells Greatly Increases Gemcitabine Uptake

(2013) Robert J. Paproski et al.   PLoS One

OAT2 catalyses efflux of glutamate and uptake of orotic acid

(2011) Christian Fork et al.   BIOCHEMICAL JOURNAL

Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique

(2011) Wei Zhang et al.   BIOCHEMICAL PHARMACOLOGY

Determination of the Phosphorylated Metabolites of Gemcitabine and of Difluorodeoxyuridine by LCMSMS

(2011) Richard J. Honeywell et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

The ergothioneine transporter controls and indicates ergothioneine activity — A review

(2011) Dirk Gründemann   PREVENTIVE MEDICINE

Nucleoside/nucleobase transporters: drug targets of the future?

(2009) Meryem Köse et al.   Future Medicinal Chemistry

New insights into the pharmacology and cytotoxicity of gemcitabine and 2',2'-difluorodeoxyuridine

(2008) S. A. Veltkamp et al.   MOLECULAR CANCER THERAPEUTICS